期刊文献+

缺血修饰白蛋白早期诊断非ST抬高型急性冠脉综合征的价值探讨 被引量:4

Evaluation on Ischemia Modified Albumin in the Early Diagnosis of Non-St-Segment Elevation Acute Coronary Syndromes
原文传递
导出
摘要 目的探讨缺血修饰白蛋白(IMA)对非ST抬高型急性冠脉综合征(NSTEACS)的早期诊断价值。方法 177例疑似NSTACS患者于胸痛发作6 h内采血,测定心肌肌钙蛋白(IcTnI);用间接白蛋白钴结合试验(ACB法)测定血清IMA值。且均经标准诊疗以及GRACE评分,并根据最终诊断分为NSTEMI组(n=34)、不稳定型心绞痛(UA)组(n=56)和非缺血性胸痛(NICP)组(n=87)。另随机选取本院同期行健康体检者58例作为健康对照组。通过绘制IMA诊断NSTEACS的受试者工作特征(ROC)曲线,取得判定IMA的最佳临界值。将IMA、心电图和cTnI单独或联合诊断与最终诊断进行综合分析。结果 NSTEMI组与UA组IMA水平无显著性差异;NSTEMI组、UA组与NICP组比较,其IMA水平均有显著性差异。ROC曲线下面积0.950,Cut-o值取67.49 U/mL时,诊断NSTEACS的敏感性和特异度分别为91.1%和86.2%。IMA水平与GRACE评分呈显著负相关。结论 IMA是早期诊断NSTEACS的敏感指标,并有助于判断患者的预后。 Objective To evaluate the early diagnostic value of ischemia modified albumin(IMA) for non-ST-segment elevation acute coronary syndromes(NSTEACS).Methods The study group consisted of 177 patients with suspected NSTEACS whose blood was collected within six hours after the onset of chest pain to determine cardiac troponin I(cTnI),and IMA was determined through the albumin cobalt binding(ACB) test.After standardized diagnosis and treatment and GRACE risk score,the patients then were divided into three groups according to the final diagnosis: the NSTEMI(non-ST-segment elevation myocardial infarction) group(n=34),the UA(unstable angina pectoris) group(n=56) and the NICP(non-ischemia chest pain) group(n=87).Meanwhile,58 people taking the routine examination in the same hospital at that time were randomly selected as the control group.With the results of IMA,ROC curve analysis was used to determine the optimal cutoff of this assay for identifying patients with NSTEACS from those with NICP.Results of IMA,ECG and cTnI were correlated with final diagnosis,and their diagnostic sensitivity and specificity were evaluated for NSTEACS.Results The IMA concentration in the serum showed no significant difference between the NSTEMI group and the UA group,whereas there were significant differences between the former two groups and the NICP group.The sensitivity and specificity at a cutoff point 67.49 U/mL were 91.1% and 86.2%,respectively when the ROC curve area was 0.950.The correlation between the IMA concentration and GRACE risk score was negative.Conclusion IMA is an early sensitive indicator for NSTEACS and a useful predictor of prognosis.
出处 《中国循证医学杂志》 CSCD 2011年第11期1251-1254,共4页 Chinese Journal of Evidence-based Medicine
基金 青岛市科技发展指导计划(编号:KZD-12)
关键词 缺血修饰白蛋白 非ST抬高型急性冠脉综合征 早期诊断 Ischemia modified albumin Non–ST-segment elevation acute coronary syndrome Early diagnosis
  • 相关文献

参考文献16

  • 1[No authors listed]. Management of unstable angina. Guide- lines--2000. The National Heart Foundation of Australia, The Car- diac Society of Australia and New Zealand. Med 1 Aust, 2000, 173 Suppl: S65-88.
  • 2Roger VL, Killian JM, Weston SA, et al. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation, 2006, 114(8): 790-797.
  • 3Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med, 1997, 337(23): 1648- 1653.
  • 4Figiel, Kasprzak JD, Peruga J, et al. Heart-type fatty acid binding protein -- a reliable marker of myocardial necrosis in a heterogene- ous group of patients with acute coronary syndrome without persis- tent ST elevation. Kardiol Pol, 2008, 66(3): 253-258.
  • 5李丽,高大胜.缺血修饰白蛋白在冠心病临床应用中的研究进展[J].中国急救医学,2008,28(8):754-758. 被引量:8
  • 6Eagle KA, Lim M], Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry, lAMA, 2004, 291(22): 2727-2733.
  • 7Roy D, Quiles J, Aldama G, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocar- diograms and negative cardiac troponin T. lnt J Cardiol, 2004, 97(2): 297-301.
  • 8Peacock F, Morris DL, Anwaruddin S, et al. Meta-analysis of is- chemiamodified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J, 2006, 152(2): 253-262.
  • 9Bar-Or D, Lau E, Winkle JV. A novel assay for cobalt-albumin binding and its potential as a maker for myocardial ischemia pre- liminary report. J Emerg Med, 2000, 19(4): 311-315.
  • 10Sinha MK, Gaze DC, Tippins IR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coro nary intervention. Circulation, 2003, 107(19): 2403-2405.

二级参考文献28

  • 1王继贵,陈新瑞,胡敏.缺血修饰清蛋白测定及评价[J].临床检验杂志,2005,23(3):177-179. 被引量:7
  • 2陈磊,黄振文,牛青原,李素姣,郭攀.在急性冠状动脉综合征早期缺血修饰白蛋白的改变及其意义[J].临床荟萃,2006,21(9):617-620. 被引量:14
  • 3唐玲丽,陈新瑞,胡敏,戈畅.运用全自动酶免分析系统测定缺血修饰白蛋白[J].实用预防医学,2006,13(4):1040-1041. 被引量:8
  • 4陈建军,李向平.急性冠状动脉综合征血清缺血修饰白蛋白的动态变化[J].中国循环杂志,2007,22(1):13-16. 被引量:18
  • 5Chu WW, Dieter RS, Stone CK. A review of clinically relevant cardiac biochemical markers [ J ]. WMJ, 2002,101 ( 3 ) : 40 - 48.
  • 6Bar - Or D, Lau E, Winkler JV. A novel assay for cobalt - album in binding and its potential as a marker for myocardial ischemia a preliminary report[J]. J Emerg Med, 2000, 19(4) : 311 -315.
  • 7Bhagavan NV, Lal EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction [ J ]. Clin Chem, 2003, 49 (4) : 581 - 585.
  • 8Roy D, Quiles J, Gaze DC, et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin[J]. Heart,2006,92( 1 ) :113 - 114.
  • 9Sinha MK, Roy D, Gaze DC, et al. Role of "ischemia modified albumin" , a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes[J]. EMJ, 2004, 21 ( 1 ) :29 - 34.
  • 10Christenson RH, Duh SH, Sanbai WR, et al. Characteristics of an albumin binding test for assessment of acute coronary syndrome patients : a muhicenter study [ J ]. Clin Chem, 2001,47 ( 3 ) :464.

共引文献7

同被引文献48

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部